Literature DB >> 29748060

Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.

Sula Mazimba1, Timothy S Welch2, Hunter Mwansa3, Khadijah K Breathett4, Jamie L W Kennedy2, Andrew D Mihalek2, William C Harding5, Manu M Mysore5, David X Zhuo5, Kenneth C Bilchick2.   

Abstract

BACKGROUND: Pulmonary artery (PA) pulsitility index (PAPi) is a novel haemodynamic index shown to predict right ventricular failure in acute inferior myocardial infarction and post left ventricular assist device surgery. We hypothesised that PAPi calculated as [PA systolic pressure - PA diastolic pressure]/right atrial pressure (RAP) would be associated with mortality in the National Institutes of Health Registry for Primary Pulmonary Hypertension (NIH-RPPH).
METHODS: The impact of PAPi, the Pulmonary Hypertension Connection (PHC) risk score, right ventricular stroke work, pulmonary artery capacitance (PAC), other haemodynamic indices, and demographic characteristics was evaluated in 272 NIH-RPPH patients using multivariable Cox proportional hazards (CPH) regression and receiver operating characteristic (ROC) analysis.
RESULTS: In the 272 patients (median age 37.7+/-15.9years, 63% female), the median PAPi was 5.8 (IQR 3.7-9.2). During 5years of follow-up, 51.8% of the patients died. Survival was markedly lower (32.8% during the first 3years) in PAPi quartile 1 compared with the remaining patients (58.5% over 3years in quartiles 2-4; p<0.0001). The best multivariable CPH survival model included PAPi, the PHC-Risk score, PAC, and body mass index (BMI). In this model, the adjusted hazard ratio for death with increasing PAPi was 0.946 (95% CI 0.905-0.989). The independent ROC areas for 5-year survival based on bivariable logistic regression for PAPi, BMI, PHC Risk, and PAC were 0.63, 0.62, 0.64, and 0.65, respectively (p<0.01). The ROC area for 5-year survival for the multivariable logistic model with all four covariates was 0.77 (p<0.0001).
CONCLUSIONS: Pulmonary artery pulsatility index was independently associated with survival in PAH, highlighting the utility of PAPi in combination with other key measures for risk stratification in this population.
Copyright © 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Heart failure; PAPi; Pulmonary hypertension

Mesh:

Year:  2018        PMID: 29748060      PMCID: PMC7175917          DOI: 10.1016/j.hlc.2018.04.280

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  32 in total

1.  The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction.

Authors:  Ravi Korabathina; Kevin S Heffernan; Vikram Paruchuri; Ayan R Patel; James O Mudd; Jordan M Prutkin; Nicole M Orr; Andrew Weintraub; Carey D Kimmelstiel; Navin K Kapur
Journal:  Catheter Cardiovasc Interv       Date:  2012-01-10       Impact factor: 2.692

2.  Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation.

Authors:  Guson Kang; Richard Ha; Dipanjan Banerjee
Journal:  J Heart Lung Transplant       Date:  2015-06-17       Impact factor: 10.247

3.  Validation of the pulmonary hypertension connection equation for survival prediction in pulmonary arterial hypertension.

Authors:  Thenappan Thenappan; Cherylanne Glassner; Mardi Gomberg-Maitland
Journal:  Chest       Date:  2011-09-01       Impact factor: 9.410

4.  The 6-minute walk test as a primary endpoint in clinical trials for pulmonary hypertension.

Authors:  Stuart Rich
Journal:  J Am Coll Cardiol       Date:  2012-09-25       Impact factor: 24.094

Review 5.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Authors:  Anton Vonk-Noordegraaf; François Haddad; Kelly M Chin; Paul R Forfia; Steven M Kawut; Joost Lumens; Robert Naeije; John Newman; Ronald J Oudiz; Steve Provencher; Adam Torbicki; Norbert F Voelkel; Paul M Hassoun
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

6.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

7.  Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Authors:  Raymond L Benza; Dave P Miller; Mardi Gomberg-Maitland; Robert P Frantz; Aimee J Foreman; Christopher S Coffey; Adaani Frost; Robyn J Barst; David B Badesch; C Gregory Elliott; Theodore G Liou; Michael D McGoon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

8.  Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

Authors:  Olivier Sitbon; Marc Humbert; Hilario Nunes; Florence Parent; Gilles Garcia; Philippe Hervé; Maurizio Rainisio; Gérald Simonneau
Journal:  J Am Coll Cardiol       Date:  2002-08-21       Impact factor: 24.094

9.  Pulmonary Artery Pulsatility Index Is Associated With Right Ventricular Failure After Left Ventricular Assist Device Surgery.

Authors:  Kevin J Morine; Michael S Kiernan; Duc Thinh Pham; Vikram Paruchuri; David Denofrio; Navin K Kapur
Journal:  J Card Fail       Date:  2015-11-10       Impact factor: 5.712

10.  Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.

Authors:  Yi Ling; Martin K Johnson; David G Kiely; Robin Condliffe; Charlie A Elliot; J Simon R Gibbs; Luke S Howard; Joanna Pepke-Zaba; Karen K K Sheares; Paul A Corris; Andrew J Fisher; James L Lordan; Sean Gaine; J Gerry Coghlan; S John Wort; Michael A Gatzoulis; Andrew J Peacock
Journal:  Am J Respir Crit Care Med       Date:  2012-07-12       Impact factor: 21.405

View more
  3 in total

1.  Association of Pulmonary Artery Pulsatility Index With Adverse Cardiovascular Events Across a Hospital-Based Sample.

Authors:  Emily K Zern; Dongyu Wang; Paula Rambarat; Samuel Bernard; Samantha M Paniagua; Elizabeth E Liu; Jenna McNeill; Jessica K Wang; Carl T Andrews; Eugene V Pomerantsev; Michael H Picard; Jennifer E Ho
Journal:  Circ Heart Fail       Date:  2022-02-09       Impact factor: 8.790

2.  Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy?

Authors:  Sofia Martin-Suarez; Gregorio Gliozzi; Giulio Giovanni Cavalli; Valentina Orioli; Antonio Loforte; Saverio Pastore; Barbara Rossi; Davide Zardin; Nazzareno Galiè; Massimiliano Palazzini; Fabio Dardi; Francesco Saia; Fabio Niro; Davide Pacini
Journal:  J Clin Med       Date:  2022-07-27       Impact factor: 4.964

3.  rBMSC/Cav-1F92A Mediates Oxidative Stress in PAH Rat by Regulating SelW/14-3-3η and CA1/Kininogen Signal Transduction.

Authors:  Wan-Cheng Yu; Hai-Ying Chen; Hong-Li Yang; Peng Xia; Cheng-Wei Zou; Tong-Wen Sun; Le-Xin Wang
Journal:  Stem Cells Int       Date:  2019-10-28       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.